Literature DB >> 15971059

Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?

K Dahl-Jørgensen1, J R Larsen, K F Hanssen.   

Abstract

Autopsy studies have shown that atherosclerosis begins in adolescence in otherwise healthy individuals, and imaging techniques have shown that atherosclerosis develops earlier and is more prevalent in children with diabetes than in age-matched healthy controls. Cardiovascular disease has now overtaken diabetic nephropathy as the leading cause of premature mortality in young adults with diabetes, and the emphasis on disease prevention has accordingly shifted to a younger age group. The majority of children and adolescents with diabetes have suboptimal blood glucose control, and this contributes to accelerated arterial disease in this age group. Other conventional risk factors for coronary heart disease also need to be considered and treated aggressively. Effective early prevention of cardiovascular disease will involve lifestyle modification and full implementation of existing treatment guidelines, and large-scale prospective studies will be needed to establish the risks and benefits of early pharmacological intervention in children and adolescents.

Entities:  

Mesh:

Year:  2005        PMID: 15971059     DOI: 10.1007/s00125-005-1832-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  90 in total

1.  The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study.

Authors:  D S Freedman; W H Dietz; S R Srinivasan; G S Berenson
Journal:  Pediatrics       Date:  1999-06       Impact factor: 7.124

2.  Smokers with IDDM experience excess morbidity. The Colorado IDDM Registry.

Authors:  E C Gay; Y Cai; S M Gale; A Baron; K J Cruickshanks; J N Kostraba; R F Hamman
Journal:  Diabetes Care       Date:  1992-08       Impact factor: 19.112

3.  Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

Authors:  S S Franklin; S A Khan; N D Wong; M G Larson; D Levy
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

4.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

Review 5.  Impaired endogenous fibrinolysis in diabetes mellitus: mechanisms and therapeutic approaches.

Authors:  T K Nordt; C Bode
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

6.  Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

Authors:  David J Graham; Judy A Staffa; Deborah Shatin; Susan E Andrade; Stephanie D Schech; Lois La Grenade; Jerry H Gurwitz; K Arnold Chan; Michael J Goodman; Richard Platt
Journal:  JAMA       Date:  2004-11-22       Impact factor: 56.272

7.  Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes.

Authors:  J R Larsen; M Brekke; L Bergengen; L Sandvik; H Arnesen; K F Hanssen; K Dahl-Jorgensen
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

8.  Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.

Authors:  Albert Wiegman; Barbara A Hutten; Eric de Groot; Jessica Rodenburg; Henk D Bakker; Harry R Büller; Eric J G Sijbrands; John J P Kastelein
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

9.  Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus.

Authors:  K Dahl-Jørgensen; T Bjøro; P Kierulf; L Sandvik; H J Bangstad; K F Hanssen
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

10.  Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

Authors:  H C McGill; C A McMahan; R E Tracy; M C Oalmann; J F Cornhill; E E Herderick; J P Strong
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-07       Impact factor: 8.311

View more
  41 in total

Review 1.  New developments in the treatment of type 1 diabetes in children.

Authors:  Thomas Danne; Karin Lange; Olga Kordonouri
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

2.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

3.  Spontaneously diabetic Ins2(+/Akita):apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis.

Authors:  John Y Jun; Zhexi Ma; Lakshman Segar
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-03-29       Impact factor: 4.310

4.  Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia.

Authors:  Karl Otfried Schwab; Jürgen Doerfer; Andreas Krebs; Kristin Krebs; Elisabeth Schorb; Kristiane Hallermann; Andrea Superti-Furga; Barbara Zieger; Winfried März; Arno Schmidt-Trucksäss; Karl Winkler
Journal:  Eur J Pediatr       Date:  2007-03-27       Impact factor: 3.183

5.  Hypolipidemic activity of Semecarpus anacardium in Streptozotocin induced diabetic rats.

Authors:  Aseervatham Jaya; Palanivelu Shanthi; Panchanatham Sachdanandam
Journal:  Endocrine       Date:  2010-06-24       Impact factor: 3.633

6.  Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-based study.

Authors:  Hanna Dis Margeirsdottir; Knut Haakon Stensaeth; Jakob Roald Larsen; Cathrine Brunborg; Knut Dahl-Jørgensen
Journal:  Diabetes Care       Date:  2010-06-08       Impact factor: 19.112

7.  Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3.

Authors:  Angela M Whetzel; David T Bolick; Catherine C Hedrick
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-17       Impact factor: 4.249

Review 8.  Dyslipidemia in youth with diabetes: to treat or not to treat?

Authors:  David M Maahs; R Paul Wadwa; Franziska Bishop; Stephen R Daniels; Marian Rewers; Georgeanna J Klingensmith
Journal:  J Pediatr       Date:  2008-10       Impact factor: 4.406

9.  High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study.

Authors:  H D Margeirsdottir; J R Larsen; C Brunborg; N C Overby; K Dahl-Jørgensen
Journal:  Diabetologia       Date:  2008-01-15       Impact factor: 10.122

10.  Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).

Authors: 
Journal:  BMC Pediatr       Date:  2009-12-17       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.